Here’s what you need to know:
1. FMX314 is the first single-port surgery solution for minimally invasive abdominal laparoscopic surgery. With fewer port-site complications, Fortimedix Surgical says the device will lead to less postoperative pain and faster recovery for patients.
2. The device is compatible with standard 15-millimeter laparoscopic trocar.
3. FMX314 received 510(k) clearance from the FDA last August.
Fortimedix Surgical is slated for the United States launch of FMX314 during the American College of Surgeons’ annual congress later this month. The device’s European commercial launch is planned for 2017.
More articles on devices and implants:
Nasseo awarded NSF grant for spinal implant research: 4 notes
Global market for cervical total disc replacement devices to reach $1.75B by 2021: 5 notes
Zimmer Biomet launches individualized TKA implant: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
